Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05842044
PHASE2

NSAID Use After Robotic Partial Nephrectomy

Sponsor: University of Miami

View on ClinicalTrials.gov

Summary

The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.

Official title: NSAID Use After Robotic Partial Nephrectomy (No-PAIN): a Randomized, Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 99 Years

Study Type

INTERVENTIONAL

Enrollment

110

Start Date

2023-09-15

Completion Date

2026-09-30

Last Updated

2025-09-05

Healthy Volunteers

No

Interventions

DRUG

Ketorolac

15-30mg Ketorolac administered via injection during intraoperative period every six (6) hours during post-surgery (inpatient) period.

DRUG

Acetaminophen

1000mg Acetaminophen administered orally during preoperative period. Standardized regimen of Acetaminophen administered during post-surgery (inpatient) period, during postoperative follow-up period.

DRUG

Oxycodone

Standardized regimen of Oxycodone administered orally (PO) on demand for moderate pain during post-surgery (inpatient) period. At discharge 5mg Oxycodone will be administered to participants on demand if pain score is greater than 7, or if participant required greater than 25mg Oxycodone during the hospitalization.

DRUG

Hydromorphone

Standardized regimen of Hydromorphone administered intravenously (IV) on demand for severe pain during post-surgery (inpatient) period.

DRUG

Ibuprofen

400mg Ibuprofen tablets administered orally (PO) every eight (8) hours for 5 days.

Locations (1)

University of Miami

Miami, Florida, United States